Prof. Freek Beekman

Leader Biomedical Imaging at TU-Delft, Netherlands

Founder & CEO of MILabs

In preclinical research we have dreamed about a 3D magnifying glass that would allow us to e.g. see various cell functions and structures in a dynamic 4D single scan, and map integrated detailed dynamics of e.g. contrast agents, tracers, pharmaceuticals, receptors and indicators of therapy response in tumours. To meet these and many other imaging needs we developed the user friendly fully integrated VECTor imaging platform (WMIC Innovation of the Year 2018) comprising:

A) down to 0.12 mm SPECT & <0.6 mm PET resolution, and proprietary sub-mm resolution positron-range free PET for e.g. 124I, 76Br, 86Y, 82Rb and 89Zr.

B) concurrent sub-mm multi-tracer PET and PET-SPECT

C) sub-second dynamic PET & SPECT

D) sub-mm resolution imaging of pharmaceuticals like 223Ra, 213Bi, 131I, 209At, 225Ac E) ultra-high performance low dose X-ray CT, and

F) Tomographic Fluorescence & Bioluminescence imaging.

In this talk, a highly adaptive and versatile nuclear, optical and structural imaging platform will be explained along with many scientific applications contributed by hundreds of world wide users. Finally the results of translating our nuclear imaging technologies into <3 mm resolution clinical SPECT for e.g. brain and paediatric imaging (G-SPECT, WMIS Innovation of the Year 2015) will be presented